| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023480382 |
| P356 | DOI | 10.1016/S1091-255X(03)00072-6 |
| P698 | PubMed publication ID | 12850669 |
| P2093 | author name string | Lu Wang | |
| Zhao-You Tang | |||
| Lun-Xiu Qin | |||
| Hui-Chuan Sun | |||
| Wei-Zhong Wu | |||
| Yin-Kun Liu | |||
| Xiao-Feng Wu | |||
| Kang-Da Liu | |||
| P2860 | cites work | Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis | Q24684263 |
| Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
| Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas | Q34344877 | ||
| Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma | Q34723692 | ||
| Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon | Q37220486 | ||
| New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis | Q38273658 | ||
| Estimates of the worldwide mortality from 25 cancers in 1990. | Q39358305 | ||
| Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis | Q40377374 | ||
| The implications of angiogenesis for the biology and therapy of cancer metastasis | Q40394139 | ||
| Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines | Q40712219 | ||
| Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells. | Q40722835 | ||
| What, if anything, is an angiogenic factor? | Q41140244 | ||
| Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy | Q41508919 | ||
| A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation | Q43457350 | ||
| Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. | Q43746137 | ||
| Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma | Q43933934 | ||
| Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells. | Q43994479 | ||
| Global cancer statistics | Q44583516 | ||
| Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma | Q47912418 | ||
| Estimates of the worldwide incidence of 25 major cancers in 1990. | Q50638996 | ||
| Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues | Q71007109 | ||
| Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor | Q71048188 | ||
| Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon beta | Q72547124 | ||
| Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis | Q73074009 | ||
| Geometric resistance and microvascular network architecture of human colorectal carcinoma | Q73246503 | ||
| Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus | Q73370593 | ||
| Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study | Q73435945 | ||
| Angiogenesis: a dynamic balance of stimulators and inhibitors | Q73447621 | ||
| Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma | Q73623064 | ||
| Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cell carcinoma treated with interferon alfa-2b | Q73689504 | ||
| The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma | Q73877559 | ||
| High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential | Q73929826 | ||
| Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel | Q74453248 | ||
| Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma | Q74595261 | ||
| Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha | Q74844581 | ||
| Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma | Q77411244 | ||
| Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study | Q77836100 | ||
| Microvessel density of hepatocellular carcinoma: its relationship with prognosis | Q77965086 | ||
| P433 | issue | 5 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 587-594 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Journal of Gastrointestinal Surgery | Q15764393 |
| P1476 | title | Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice | |
| P478 | volume | 7 |
| Q34995738 | A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinoma. |
| Q80376325 | A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma |
| Q34265805 | Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis |
| Q45351713 | Adjuvant interferon therapy after surgical treatment for hepatitis B/C virus-related hepatocellular carcinoma: A meta-analysis |
| Q96135356 | Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment |
| Q35701281 | Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives |
| Q51656262 | Angiogenesis inhibitors and hypoxia. |
| Q36235557 | Antiangiogenic strategies in hepatocellular carcinoma: current status |
| Q38100807 | Antiviral therapy after curative treatment of hepatitis B/C virus-related hepatocellular carcinoma: A systematic review of randomized trials |
| Q50558502 | Antiviral therapy for hepatitis C is associated with improved clinical outcomes in patients with advanced fibrosis. |
| Q54544776 | Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation. |
| Q59354217 | Complete cure of a patient with HBV-associated hepatocellular carcinoma with lung metastasis using interferon and survival up to 108 months: A case report and literature review |
| Q36452709 | Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma |
| Q34634386 | Direct transformation of lung microenvironment by interferon-α treatment counteracts growth of lung metastasis of hepatocellular carcinoma |
| Q34998414 | Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis |
| Q42914421 | Effect of TALEN-mediated IL-6 knockout on cell proliferation, apoptosis, invasion and anti-cancer therapy in hepatocellular carcinoma (HCC-LM3) cells |
| Q36406952 | Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation. |
| Q33726314 | Herbal compound "Songyou Yin" reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice |
| Q43595549 | High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection |
| Q35829509 | Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma |
| Q37413261 | Inhibitory effect of interferon-alpha-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice |
| Q21296797 | Interferon lambda: a new sword in cancer immunotherapy |
| Q45372651 | Interferon‐α therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus‐related hepatocellular carcinoma |
| Q43648648 | Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study |
| Q39730685 | Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma |
| Q45492170 | Low-dose, long-term, intermittent interferon-alpha-2b therapy after radical treatment by radiofrequency ablation delays clinical recurrence in patients with hepatitis C virus-related hepatocellular carcinoma |
| Q33370654 | Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial |
| Q38330577 | Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells |
| Q24299104 | SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion |
| Q24321596 | SP100 inhibits ETS1 activity in primary endothelial cells |
| Q40446067 | Synergistic effects of interferon-alpha in combination with chemoradiation on human pancreatic adenocarcinoma |
| Q64256831 | The different effects of adefovir dipivoxil and telbivudine on the prognosis of hepatitis b virus-related hepatocellular carcinoma patients after curative resection |
| Q33593219 | Viral hepatitis and hepatocellular carcinoma: etiology and management |
| Q55415024 | miR-370 regulates ISG15 expression and influences IFN-α sensitivity in hepatocellular carcinoma cells. |
Search more.